As of 4:00pm ET
| -0.35 / -4.09%|
The 7 analysts offering 12-month price forecasts for ImmunoGen Inc have a median target of 10.00, with a high estimate of 16.00 and a low estimate of 3.00. The median estimate represents a +21.95% increase from the last price of 8.20.
The current consensus among 9 polled investment analysts is to Buy stock in ImmunoGen Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.